Johnson & Johnson plans to begin testing its experimental COVID-19 vaccine in youths aged 12 to 18 as quickly as potential, an organization government stated at a gathering held by the US Facilities for Illness Management and Prevention (CDC) on Friday.
“We plan to enter youngsters as quickly as we probably can, however very rigorously when it comes to security,” J&J’s Dr. Jerry Sadoff instructed a digital assembly of the CDC’s Advisory Committee on Immunization Practices.
Relying on security and different elements, the corporate plans to check in even youthful youngsters afterwards, Sadoff, a vaccine analysis scientist at J&J’s Janssen unit, stated.
J&J began testing the vaccine in adults in a 60,000-volunteer Part III examine in late September. It needed to pause the trial earlier this month due to a critical medical occasion in a single participant. The examine resumed final week.
Rival drugmaker Pfizer Inc has already begun testing the COVID-19 vaccine it’s growing with Germany’s BioNTech in youngsters as younger as 12.
(Aside from the headline, this story has not been edited by NDTV workers and is revealed from a syndicated feed.)